Molbio Diagnostics Limited (NSE:MOLBIO)
India · Delayed Price · Currency is INR 1,094.75
-49.40 (-4.32%)
Aug 28, 2026, 3:29 PM IST
Molbio Diagnostics Market Cap
Molbio Diagnostics has a market cap or net worth of 123.44 billion as of August 28, 2026.
Market Cap
123.44B
Enterprise Value
125.63B
Revenue
14.46B
Ranking
n/a
PE Ratio
74.12
Stock Price
1,094.75
ChartMarket Cap Chart
Since August 17, 2026, Molbio Diagnostics's market cap has increased from 117.46B to 123.44B, an increase of 5.09%. That is a compound annual growth rate of 419.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 123.44B | -4.32% |
| Aug 27, 2026 | 129.01B | -7.64% |
| Aug 26, 2026 | 139.69B | 0.94% |
| Aug 25, 2026 | 138.40B | 2.34% |
| Aug 24, 2026 | 135.23B | 9.18% |
| Aug 21, 2026 | 123.86B | 5.96% |
| Aug 20, 2026 | 116.89B | - |
| Aug 19, 2026 | 116.89B | -6.68% |
| Aug 18, 2026 | 125.26B | 6.64% |
| Aug 17, 2026 | 117.46B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.59T |
| Divi's Laboratories | 2.41T |
| Apollo Hospitals Enterprise | 1.27T |
| Zydus Lifesciences | 1.19T |
| Rainbow Children's Medicare | 146.36B |
| Indegene | 136.68B |
| Sudeep Pharma | 128.10B |
| CORONA Remedies | 127.41B |